AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 64 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $44,000 | +100.0% | 4,800 | 0.0% | 0.00% | – |
| Q1 2020 | $22,000 | -38.9% | 4,800 | 0.0% | 0.00% | – |
| Q4 2019 | $36,000 | -50.0% | 4,800 | -50.0% | 0.00% | – |
| Q3 2019 | $72,000 | +125.0% | 9,600 | +100.0% | 0.00% | – |
| Q2 2019 | $32,000 | -15.8% | 4,800 | 0.0% | 0.00% | – |
| Q1 2019 | $38,000 | +8.6% | 4,800 | 0.0% | 0.00% | – |
| Q4 2018 | $35,000 | -22.2% | 4,800 | 0.0% | 0.00% | – |
| Q3 2018 | $45,000 | -10.0% | 4,800 | 0.0% | 0.00% | – |
| Q2 2018 | $50,000 | – | 4,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $891,000 | 15.31% |
| Aisling Capital Management LP | 1,691,151 | $13,445,000 | 2.68% |
| GREAT POINT PARTNERS LLC | 900,000 | $7,155,000 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $22,639,000 | 1.40% |
| Altium Capital Management LP | 609,689 | $4,847,000 | 1.27% |
| Sio Capital Management, LLC | 446,000 | $3,546,000 | 1.13% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,953,000 | 1.12% |
| Samsara BioCapital, LLC | 883,720 | $7,026,000 | 1.10% |
| Lion Point Capital, LP | 300,000 | $2,385,000 | 0.45% |
| Abingworth LLP | 240,500 | $1,912,000 | 0.43% |